Francesca Zucchi

Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.

Journal: Expert review of clinical pharmacology

Published: August 05, 2026

How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1.

Journal: Journal of bone and mineral metabolism

Published: September 12, 2025

Osteoclast in CRPS: an alleged guilty fully acquitted.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: December 10, 2024

Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study.

Journal: Calcified tissue international

Published: April 23, 2024

Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With Neridronate.

Journal: Clinical medicine insights. Arthritis and musculoskeletal disorders

Published: February 16, 2024

How the COVID-19 pandemic affected bone health: a retrospective, longitudinal study on denosumab persistence from the epicentre of European spreading.

Journal: Archives of osteoporosis

Published: April 17, 2023

Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: September 17, 2022

Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.

Journal: Therapeutic advances in musculoskeletal disease

Published: August 18, 2022

Long-term use of burosumab for the treatment of tumor-induced osteomalacia.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: March 03, 2022

Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.

Journal: Endocrine

Published: January 09, 2022

Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.

Why do bisphosphonates work in the treatment of CRPS? A translational pharmacological perspective to solve a conundrum.

How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1.

How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1.

Osteoclast in CRPS: an alleged guilty fully acquitted.

Osteoclast in CRPS: an alleged guilty fully acquitted.

Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study.

Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study.

Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With Neridronate.

Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With Neridronate.

How the COVID-19 pandemic affected bone health: a retrospective, longitudinal study on denosumab persistence from the epicentre of European spreading.

How the COVID-19 pandemic affected bone health: a retrospective, longitudinal study on denosumab persistence from the epicentre of European spreading.

Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.

Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.

Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.

Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.

Long-term use of burosumab for the treatment of tumor-induced osteomalacia.

Long-term use of burosumab for the treatment of tumor-induced osteomalacia.

Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.

Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.

A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.

A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.

Tumor induced osteomalacia: A single center experience on 17 patients.

Tumor induced osteomalacia: A single center experience on 17 patients.